Canada· CA-DIN-02544903
VELSIPITY
A etrasimod product containing etrasimod (etrasimod l-arginine), registered in Canada by PFIZER CANADA ULC. The same ATC class is registered in 13 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Etrasimod is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AE05 (etrasimod), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 8 of them publish a price we can compare per daily dose
Etrasimod · ATC L04AE05
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of etrasimod costs, country by country.
Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Etrasimod · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$35.97
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- ETRASIMOD (ETRASIMOD L-ARGININE)
- Manufacturer
- PFIZER CANADA ULC
- Country
- Canada (CA)
- ATC code
- L04AE05
- ATC class
- Etrasimod
- Defined daily dose
- 2 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Etrasimod in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomVelsipity 2mg tabletsPfizer Ltd
- SwitzerlandVelsipity 2 mg, FilmtablettenPfizer AG
- SpainVELSIPITY 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPfizer Europe Ma Eeig
- NorwayVelsipityPfizer Europe MA EEIG
- PolandVelsipityPfizer Europe MA EEIG
- SwedenVelsipity 2 mg Filmdragerad tablettPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Velsipity
- Liechtenstein · Velsipity
- Norway · Velsipity
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e4951a88-0e75-4c0a-a470-ad60ef52aefb GET /v1/drugs/e4951a88-0e75-4c0a-a470-ad60ef52aefb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02544903",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "L04AE05",
"schedule": [
"Prescription"
],
"drug_code": "103353",
"strengths": [
"2 MG"
],
"ahfs_class": null,
"substances": [
"ETRASIMOD (ETRASIMOD L-ARGININE)"
],
"product_categorization": null
}See everything about etrasimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.